Chris Murphy actually said...

we very much look forward to engaging with Congress as we seek to shape what that follow-on or future legal framework will look like.

I think there is a reason why it is Article 2 that lays out the administration's powers, and not Article 1.

I think this increasing avalanche of good news and positive data about the implementation of the Affordable Care Act is going to ultimately ...

Thank you for your leadership on the breakthrough therapies provision in the Food and Drug Administration Safety and Innovation Act (FDASIA)...